Evidence map›Paper›PMID 36362012›Full record

ArticleInternational journal of molecular sciences2022

Increased Weight Gain and Insulin Resistance in HF-Fed PLTP Deficient Mice Is Related to Altered Inflammatory Response and Plasma Transport of Gut-Derived LPS.

Lorène J Lebrun, Gaëtan Pallot, Maxime Nguyen, Annabelle Tavernier, Alois Dusuel, Thomas Pilot, Valérie Deckert, Isabelle Dugail, Naig Le Guern, Jean-Paul Pais De Barros and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Review
  7. The Effect of Enteric-Derived Lipopolysaccharides on Obesity.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Lorène J LebrunINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Gaëtan PallotINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Maxime NguyenINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.ORCID 0000-0002-2334-1487
Annabelle TavernierINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.ORCID 0000-0002-5744-2876
Alois DusuelINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Thomas PilotINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Valérie DeckertINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Isabelle DugailFaculté de Médecine Pitié-Salpêtrière, UMR1269, 75000 Paris, France.ORCID 0000-0003-3631-2252
Naig Le GuernINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Jean-Paul Pais De BarrosINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Anissa BenkhaledINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Hélène ChoubleyINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Laurent LagrostINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
David MassonINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.ORCID 0000-0003-1692-0699
Thomas GautierINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.
Jacques GroberINSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France.ORCID 0000-0003-0503-4819
Inserm · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial lipopolysaccharides (LPS, endotoxins) are found in high amounts in the gut lumen. LPS can cross the gut barrier and pass into the blood (endotoxemia), leading to low-grade inflammation, a common scheme in metabolic diseases. Phospholipid transfer protein (PLTP) can transfer circulating LPS to plasma lipoproteins, thereby promoting its detoxification. However, the impact of PLTP on the metabolic fate and biological effects of gut-derived LPS is unknown. This study aimed to investigate the influence of PLTP on low-grade inflammation, obesity and insulin resistance in relationship with LPS intestinal translocation and metabolic endotoxemia. Wild-type (WT) mice were compared with

Indexed as

Diet, High-FatEndotoxemiaInflammationInsulin ResistanceWeight GainAnimalsLipopolysaccharidesLipoproteinsMiceObesityPhospholipid Transfer ProteinsLipopolysaccharidesLipoproteinsphospholipid transfer protein, mousePhospholipid Transfer Proteinsdietary fatinflammationlipid metabolismLPS (lipopolysaccharides)obesityPLTP (phospholipid transfer protein)

Identifiers

PMID36362012
PMCPMC9654699
OpenAlexW4307943843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.